Stoke Therapeutics, Inc. (STOK) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$35.52
Day's range
$38.69

Stoke Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RTW INVESTMENTS, LP 05/15/2026 5.62 M $183.10 M   1.38% 9.50%
BLACKROCK, INC. 05/13/2026 5.39 M $175.36 M   3.32% 9.09%
FMR LLC 05/15/2026 5.38 M $175.29 M   -3.88% 9.09%
LYNX1 CAPITAL MANAGEMENT LP 05/04/2026 4.76 M $155.11 M   -11.86% 8.04%
REDMILE GROUP, LLC 05/15/2026 4.16 M $135.58 M   3.22% 7.03%
MORGAN STANLEY 05/15/2026 3.42 M $111.46 M   -3.47% 5.78%
BAKER BROS. ADVISORS LP 05/15/2026 3.34 M $108.64 M   0.00% 5.63%
TORONTO DOMINION BANK 05/15/2026 3.17 M $103.32 M   0.00% 5.36%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 3.10 M $100.80 M   320.73% 5.23%
BVF INC/IL 05/15/2026 2.55 M $82.95 M   12.44% 4.30%
05/15/2026 2.36 M $76.70 M   100.00% 3.98%
STATE STREET CORP 05/15/2026 2.28 M $74.12 M   -8.87% 3.84%
SIREN, L.L.C. 05/14/2026 2.00 M $64.97 M   -11.21% 3.37%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 1.93 M $62.98 M   419.47% 3.27%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 05/15/2026 1.82 M $59.37 M   0.00% 3.08%
JANUS HENDERSON GROUP PLC 05/18/2026 1.61 M $52.46 M   11.15% 2.72%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.32 M $43.06 M   13.39% 2.23%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 1.13 M $36.87 M   -10.76% 1.91%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 989.94 K $32.23 M   19.68% 1.67%
ASSENAGON ASSET MANAGEMENT S.A. 04/20/2026 907.02 K $29.53 M   -26.12% 1.53%
GOLDMAN SACHS GROUP INC 05/15/2026 830.70 K $27.05 M   -27.31% 1.40%
BIOIMPACT CAPITAL LLC 05/15/2026 767.04 K $24.97 M   -0.42% 1.30%
OPALEYE MANAGEMENT INC. 05/15/2026 700.00 K $22.79 M   0.72% 1.18%
TROLUCE CAPITAL ADVISORS LLC 05/15/2026 652.80 K $21.26 M   100.00% 1.10%
BAILLIE GIFFORD & CO 05/08/2026 575.18 K $18.73 M   132.96% 0.97%
BANK OF AMERICA CORP /DE/ 05/18/2026 543.10 K $17.68 M   163.43% 0.92%
CANDRIAM S.C.A. 04/30/2026 502.02 K $16.35 M   12.39% 0.85%
TANG CAPITAL MANAGEMENT LLC 05/15/2026 500.00 K $16.28 M   0.00% 0.84%
MILLENNIUM MANAGEMENT LLC 05/15/2026 472.14 K $15.37 M   100.00% 0.80%
05/08/2026 462.68 K $15.06 M   100.00% 0.78%
ERSTE ASSET MANAGEMENT GMBH 05/11/2026 446.00 K $14.17 M   12.63% 0.75%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 437.18 K $14.23 M   6.39% 0.74%
NORTHERN TRUST CORP 05/14/2026 431.63 K $14.05 M   7.06% 0.73%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 356.95 K $11.62 M   100.00% 0.60%
PARKMAN HEALTHCARE PARTNERS LLC 05/15/2026 336.52 K $10.96 M   -21.77% 0.57%
GRANAHAN INVESTMENT MANAGEMENT, LLC 05/15/2026 335.59 K $10.93 M   75.34% 0.57%
ARTISAN PARTNERS LIMITED PARTNERSHIP 05/13/2026 315.49 K $10.27 M   100.00% 0.53%
JPMORGAN CHASE & CO 05/13/2026 265.47 K $8.43 M   -4.48% 0.45%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2026 250.91 K $8.17 M   100.00% 0.42%
BIRCHVIEW CAPITAL, LP 05/15/2026 210.00 K $6.84 M   -19.23% 0.35%
CAPTION MANAGEMENT, LLC 05/15/2026 200.00 K $6.51 M   100.00% 0.34%
FIRST TRUST ADVISORS LP 05/13/2026 163.46 K $5.32 M   0.48% 0.28%
UBS GROUP AG 05/05/2026 158.30 K $5.15 M   -6.72% 0.27%
INVESCO LTD. 05/12/2026 150.05 K $4.89 M   -42.19% 0.25%
BANK OF NEW YORK MELLON CORP 05/05/2026 143.41 K $4.67 M   1.85% 0.24%
FRANKLIN RESOURCES INC 05/13/2026 142.79 K $4.65 M   7.99% 0.24%
DAFNA CAPITAL MANAGEMENT LLC 05/15/2026 130.88 K $4.26 M   20.21% 0.22%
CITADEL ADVISORS LLC 05/15/2026 123.02 K $4.01 M   676.12% 0.21%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 05/15/2026 119.23 K $3.88 M   -5.64% 0.20%
GILDER GAGNON HOWE & CO LLC 05/15/2026 112.63 K $3.67 M   -8.02% 0.19%

Stoke Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 229 institutional investors and hedge funds held shares of Stoke Therapeutics Inc. The most heavily invested institutionals were:

RTW INVESTMENTS, LP: 5.62 M

BlackRock, Inc.: 5.39 M

FMR LLC: 5.38 M

Lynx1 Capital Management LP: 4.76 M

Redmile Group, LLC: 4.16 M

MORGAN STANLEY: 3.42 M

120.08% of Stoke Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 99.64 M shares in the last 24 months. This purchase volume represents approximately $3.82 B in transactions.